These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38808200)

  • 1. Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods.
    Thompson E; Tardif J; Ujeneza M; Badea A; Green TC; McKee H; McKenzie M; Park JN
    Drug Alcohol Depend Rep; 2024 Jun; 11():100241. PubMed ID: 38808200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications.
    Sisco E; Nestadt DF; Bloom MB; Schneider KE; Elkasabany RA; Rouhani S; Sherman SG
    Drug Test Anal; 2023 Dec; ():. PubMed ID: 38043944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
    Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
    Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study.
    Park JN; Serafinski R; Ujeneza M; McKenzie M; Tardif J; Krotulski AJ; Badea A; Grossman ER; Green TC
    Drug Alcohol Depend Rep; 2024 Jun; 11():100247. PubMed ID: 38974777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine - United States, January 2019-June 2022.
    Kariisa M; O'Donnell J; Kumar S; Mattson CL; Goldberger BA
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(26):721-727. PubMed ID: 37384558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
    Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS/MS) in illicit drug samples collected in Chicago, IL.
    Whitehead HD; Hayes KL; Swartz JA; Prete E; Robison-Taylor L; Mackesy-Amiti ME; Jimenez AD; Lieberman M
    Forensic Chem; 2023 May; 33():. PubMed ID: 36910306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid overdoses involving xylazine in emergency department patients: a multicenter study.
    Love JS; Levine M; Aldy K; Brent J; Krotulski AJ; Logan BK; Vargas-Torres C; Walton SE; Amaducci A; Calello D; Hendrickson R; Hughes A; Kurt A; Judge B; Pizon A; Schwarz E; Shulman J; Wiegan T; Wax P; Manini AF
    Clin Toxicol (Phila); 2023 Mar; 61(3):173-180. PubMed ID: 37014353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA.
    Warp PV; Hauschild M; Serota DP; Ciraldo K; Cruz I; Bartholomew TS; Tookes HE
    Harm Reduct J; 2024 Mar; 21(1):64. PubMed ID: 38491467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022.
    Cano M; Daniulaityte R; Marsiglia F
    JAMA Netw Open; 2024 Jan; 7(1):e2350630. PubMed ID: 38180756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.
    Zagorski CM; Hosey RA; Moraff C; Ferguson A; Figgatt M; Aronowitz S; Stahl NE; Hill LG; McElligott Z; Dasgupta N
    Harm Reduct J; 2023 Sep; 20(1):141. PubMed ID: 37777769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program.
    Vohra V; Stroh-Steiner GK; Jones P
    Clin Toxicol (Phila); 2023 Dec; 61(12):1040-1046. PubMed ID: 38088581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and Uptake of the Massachusetts Drug Supply Data Stream: A Statewide Public Health-Public Safety Partnership Drug Checking Program.
    Green TC; Olson R; Jarczyk C; Erowid E; Erowid F; Thyssen S; Wightman R; Del Pozo B; Michelson L; Consigli A; Reilly B; Ruiz S
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(Suppl 6):S347-S354. PubMed ID: 36194805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costing analysis of a point-of-care drug checking program in Rhode Island.
    Cepeda JA; Thompson E; Ujeneza M; Tardif J; Walsh T; Morales A; Rosen JG; Green TC; Park JN
    Drug Alcohol Depend; 2023 Dec; 253():111028. PubMed ID: 38000322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021.
    Korn WR; Stone MD; Haviland KL; Toohey JM; Stickle DF
    Clin Chim Acta; 2021 Oct; 521():151-154. PubMed ID: 34265257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019.
    Johnson J; Pizzicato L; Johnson C; Viner K
    Inj Prev; 2021 Aug; 27(4):395-398. PubMed ID: 33536231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
    Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
    Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative LC-MS/MS analysis of Xylazine, p-Fluorofentanyl, Fentanyl and Fentanyl-Related compounds in postmortem blood.
    Truver MT; Brogan SC; Jaeschke EA; Kinsey AM; Hoyer JL; Chronister CW; Crosby MM; Goldberger BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124059. PubMed ID: 38489939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
    Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
    Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.